CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics Market Cap : 442.44M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 442.44M |
| November 19, 2026 | 446.80M |
| November 18, 2026 | 409.75M |
| November 17, 2026 | 422.83M |
| November 16, 2026 | 432.64M |
| November 13, 2026 | 444.62M |
| November 12, 2026 | 444.62M |
| November 11, 2026 | 464.24M |
| November 10, 2026 | 431.55M |
| November 09, 2026 | 431.55M |
| November 06, 2026 | 477.32M |
| November 05, 2026 | 466.42M |
| November 04, 2026 | 512.19M |
| November 03, 2026 | 475.14M |
| November 02, 2026 | 485.92M |
| October 30, 2026 | 509.88M |
| October 29, 2026 | 498.99M |
| October 28, 2026 | 514.24M |
| October 27, 2026 | 503.35M |
| October 26, 2026 | 484.83M |
| October 23, 2026 | 505.53M |
| October 22, 2026 | 531.67M |
| October 21, 2026 | 522.96M |
| October 20, 2026 | 546.93M |
| October 19, 2026 | 509.88M |
| Date | Value |
|---|---|
| October 16, 2026 | 496.81M |
| October 15, 2026 | 525.14M |
| October 14, 2026 | 485.92M |
| October 13, 2026 | 506.62M |
| October 12, 2026 | 527.32M |
| October 09, 2026 | 560.00M |
| October 08, 2026 | 538.21M |
| October 07, 2026 | 555.64M |
| October 06, 2026 | 557.82M |
| October 05, 2026 | 562.18M |
| October 02, 2026 | 557.82M |
| October 01, 2026 | 573.08M |
| September 30, 2026 | 592.69M |
| September 29, 2026 | 599.22M |
| September 28, 2026 | 586.15M |
| September 25, 2026 | 588.33M |
| September 24, 2026 | 599.22M |
| September 23, 2026 | 605.76M |
| September 22, 2026 | 640.62M |
| September 21, 2026 | 601.40M |
| September 18, 2026 | 601.40M |
| September 17, 2026 | 614.48M |
| September 16, 2026 | 602.49M |
| September 15, 2026 | 586.15M |
| September 14, 2026 | 697.28M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 95.20B |
| Arcturus Therapeutics Holdings, Inc. | 212.03M |
| Corvus Pharmaceuticals, Inc. | 815.37M |
| ACADIA Pharmaceuticals, Inc. | 2.956B |
| Alnylam Pharmaceuticals, Inc. | 19.25B |
Market Cap Related Metrics
| PS Ratio | 28.42 |
| Price to Book Value | 1.553 |
| Price | 2.03 |
| Earnings Yield | -22.76% |